Eclipse raised $1.3 billion across two funds to back companies in robotics, manufacturing and energy. Founder and CEO Lior Susan discussed the fundraise on Bloomberg Tech. The sizeable close signals sustained VC appetite for hard-tech and industrial startups and should improve funding availability for early- and growth-stage physical-industry companies.
Fresh, patient capital into capital‑heavy hardware creates a predictable multi‑year demand tail for manufacturing services, test equipment and higher‑end components — not a same‑quarter revenue pop. Expect incremental revenue to skew to contract manufacturers and test/lithography vendors over 12–36 months as startups move from prototypes to low‑volume production, which benefits balance‑sheet heavy providers that can finance tooling, capacity and wafer masks. Second‑order supply effects will show up faster: 3–12 months of wage and component inflation (motors, power electronics, high‑precision sensors) as firms compete for embedded systems, and 6–18 months of hiring pressure in controls/software engineering. That dynamic favors firms with integrated supply chains and captive fabs or long‑term contracts (i.e., scale players) and penalizes narrow niche suppliers who lack pricing power; it also raises M&A probability as incumbents buy scale rather than build it internally over a 12–36 month window. Key downside scenarios are macro‑driven: a sustained rate shock or public IPO stall would compress late‑stage valuations and force markdowns or fire sales in 6–18 months, while execution risk (manufacturing yield, certification delays) can wipe out early hardware valuations fast. Watch regulatory/export restrictions on advanced tooling and semiconductors as an asymmetric tail risk that can materially delay exits and re‑rate the entire hardware stack.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
